Dr. Malloy has held management and executive leadership positions in rapidly growing life science and diagnostics companies for over 20 years. His most recent role was Senior Vice President and General Manager of Life Sciences and Applied Markets at Illumina, a leading developer and supplier of genetic analysis instrumentation, assays and software. In this role he oversaw the company’s core platform technologies and is responsible for a P&L of over $1B serving the life sciences and applied markets (Agrigenomics, Micriobiology, Transplant Biology, Forensics, Complex Diseases and Healthy Genomes). Prior to joining Illumina in 2002, Malloy built and managed commercial training, support and validation services at Biosite Inc., a leading provider of rapid diagnostics products, where he helped build the point of care cardiovascular diagnostics test market. Malloy had previously held several commercial management positions at QIAGEN, Inc., a provider of molecular biology reagents for the life sciences, veterinary, diagnostics, and applied markets. Dr Malloy currently serves on the Board of Directors for Organovo (ONVO), is on the Board of Trustees for the Pacific Ridge School, and is on the Dean’s Advisory Board for the University of Delaware where he completed his M.S. and Ph.D. He has 12 peer-reviewed publications and book chapters, dozens of invited and contributed scientific presentations and has been a reviewer for various scientific journals.